Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3762720013 | Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3762721012 | Nitroglycerin 1.5 mg prolonged-release buccal tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3762722017 | Glyceryl trinitrate 1.5 mg prolonged-release buccal tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Is a | Product containing glyceryl trinitrate (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has active ingredient | Glyceryl trinitrate | false | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has manufactured dose form | Sublingual tablet | false | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Is a | Product containing glyceryl trinitrate in sublingual dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has manufactured dose form | Oromucosal AND/OR gingival dosage form | false | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has manufactured dose form | Prolonged-release buccal tablet | true | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has presentation strength numerator value | 1.5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Some | 1 | |
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has precise active ingredient | Glyceryl trinitrate | true | Inferred relationship | Some | 1 | |
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Is a | Product containing only glyceryl trinitrate in oromucosal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely glyceryl trinitrate 1.5 milligram/1 each prolonged-release buccal tablet (clinical drug) | Has basis of strength substance (attribute) | Glyceryl trinitrate | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Description inactivation indicator reference set
FHIR